200 related articles for article (PubMed ID: 1380168)
1. Spontaneous malignant transformation of melanocytes explanted from Wf/Wf mice with a Kit kinase-domain mutation.
Larue L; Dougherty N; Porter S; Mintz B
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7816-20. PubMed ID: 1380168
[TBL] [Abstract][Full Text] [Related]
2. Mast cell number in the skin of heterozygotes reflects the molecular nature of c-kit mutation.
Tsujimura T; Koshimizu U; Katoh H; Isozaki K; Kanakura Y; Tono T; Adachi S; Kasugai T; Tei H; Nishimune Y
Blood; 1993 May; 81(10):2530-8. PubMed ID: 7683920
[TBL] [Abstract][Full Text] [Related]
3. Instability at the W/c-kit locus in mice: analysis of melanocyte cell lines derived from reversion spots.
De Sepulveda P; Peyrieras N; Panthier JJ
Oncogene; 1994 Sep; 9(9):2655-61. PubMed ID: 7520149
[TBL] [Abstract][Full Text] [Related]
4. Ectopic expression of a c-kitW42 minigene in transgenic mice: recapitulation of W phenotypes and evidence for c-kit function in melanoblast progenitors.
Ray P; Higgins KM; Tan JC; Chu TY; Yee NS; Nguyen H; Lacy E; Besmer P
Genes Dev; 1991 Dec; 5(12A):2265-73. PubMed ID: 1721031
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice.
Nocka K; Majumder S; Chabot B; Ray P; Cervone M; Bernstein A; Besmer P
Genes Dev; 1989 Jun; 3(6):816-26. PubMed ID: 2473008
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic reversions at the W/Kit locus mediated by mitotic recombination in mice.
De Sepulveda P; Guenet JL; Panthier JJ
Mol Cell Biol; 1995 Nov; 15(11):5898-905. PubMed ID: 7565742
[TBL] [Abstract][Full Text] [Related]
7. W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor.
Reith AD; Rottapel R; Giddens E; Brady C; Forrester L; Bernstein A
Genes Dev; 1990 Mar; 4(3):390-400. PubMed ID: 1692559
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.
Giebel LB; Spritz RA
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8696-9. PubMed ID: 1717985
[TBL] [Abstract][Full Text] [Related]
9. Effects of mutations at the W locus (c-kit) on inner ear pigmentation and function in the mouse.
Cable J; Huszar D; Jaenisch R; Steel KP
Pigment Cell Res; 1994 Feb; 7(1):17-32. PubMed ID: 7521050
[TBL] [Abstract][Full Text] [Related]
10. recessive spotting: a linked locus that interacts with W/Kit but is not allelic.
Bennett DC; Trayner ID; Piao X; Easty DJ; Klüppel M; Alexander WS; Wagner EF; Bernstein A
Genes Cells; 1998 Apr; 3(4):235-44. PubMed ID: 9663658
[TBL] [Abstract][Full Text] [Related]
11. c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes.
Monsel G; Ortonne N; Bagot M; Bensussan A; Dumaz N
Oncogene; 2010 Jan; 29(2):227-36. PubMed ID: 19802003
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibitors of c-KIT block mutant c-KIT mediated migration of melanocytes and melanoma cells in vitro and in vivo.
Posch C; Moslehi H; Sanlorenzo M; Green G; Vujic I; Panzer-Grümayer R; Rappersberger K; Ortiz-Urda S
Oncotarget; 2016 Jul; 7(29):45916-45925. PubMed ID: 27322141
[TBL] [Abstract][Full Text] [Related]
13. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.
Chabot B; Stephenson DA; Chapman VM; Besmer P; Bernstein A
Nature; 1988 Sep; 335(6185):88-9. PubMed ID: 2457811
[TBL] [Abstract][Full Text] [Related]
14. Loss of c-kit expression in cultured melanoma cells.
Lassam N; Bickford S
Oncogene; 1992 Jan; 7(1):51-6. PubMed ID: 1371338
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the c-kit protooncogene in the human developmental defect piebald trait.
Fleischman RA; Saltman DL; Stastny V; Zneimer S
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10885-9. PubMed ID: 1720553
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
[TBL] [Abstract][Full Text] [Related]
17. Long-range genomic rearrangements upstream of Kit dysregulate the developmental pattern of Kit expression in W57 and Wbanded mice and interfere with distinct steps in melanocyte development.
Klüppel M; Nagle DL; Bucan M; Bernstein A
Development; 1997 Jan; 124(1):65-77. PubMed ID: 9006068
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of Trp53 rescues the male fertility defects of Kit(W-v) mice but has no effect on the survival of melanocytes and mast cells.
Jordan SA; Speed RM; Bernex F; Jackson IJ
Dev Biol; 1999 Nov; 215(1):78-90. PubMed ID: 10525351
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
20. Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo.
Mackenzie MA; Jordan SA; Budd PS; Jackson IJ
Dev Biol; 1997 Dec; 192(1):99-107. PubMed ID: 9405100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
